This RfA requests that Applicants respond in detail to Phase 1 – delivering DHALP as an online 18- month program, including:

Closing date

The Stress and Stroke Predictor is a digital prediction tool that uses 3 biomarkers and blood pressure readings to accurately predict and quantify future risk of chronic stress and resulting diabetes, ischemic heart disease and stroke. Using a proprietary algorithm, formulated from 30 years of...

This is a high-tech lighting solution that simulates a real skylight, having application to environments that have little or no access to natural lighting. This type of circadian lighting technology has also been known to have a positive effect on the wellness of individuals.  

The development of a mobile molecular diagnostic device, the Akili MDx, to assist healthcare professionals with accurate diagnostics in the lab and in-field.The Akili MDx is in development and will assist in quick & early pathogen detection at a genetic level of HIV, Influenza, SARS-CoV-2 and future...

The Small Enterprise Development Agency (Seda) and Technology Innovation Agency (TIA)  have organised a series of webinars on various support programmes available to start-ups, innovators and entrepreneurs at TIA. 

Webinars 

  • TIA  Grassroots Innovation Programme, 09 September 2020 -  Click h...
Event end date

The Swiss - SA Venture Leaders Programme hosted by the Technology Innovation Agency and the University of Basel aims to:

Closing date

AlertCent is an ICT Health Care Management system that keeps healthcare professionals in medical facilities, such as frail cares close to their patients by allowing for fast, easy, and secure patient observations recording, monitoring, management, and reporting. This is done through the use of...

PATH is the leader in global health innovation. An international nonprofit organization, we save lives and improve health, especially among women and children. We accelerate innovation across five platforms— vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs.

Closing date

The problem

Testing for the SARS-CoV-2 infection currently has a significant impact on clinical laboratories globally concerning capacity building; scale-up of testing, stock-out of laboratory supplies, and high cost of reagents. The Nucleic Acid Amplification Test (NAAT) recommended by the World...

The COVID-19 disease causes pulmonary infections, which could be observed by CT images of a patient's lungs as well as chest X-ray images. Clinicians have been able to observe and diagnose similar infections such as pneumonia using the aforementioned approach. By using a dataset of chest x-ray...